Lymfit exercise intervention for Lymphoma

Jewish General Hospital, Montreal, Canada
Lymphoma+1 More ConditionsLymfit exercise intervention - Behavioral
18 - 39
All Sexes
What conditions do you have?

Study Summary

This trial will test whether an exercise program using mobile technology can improve fitness and quality of life for lymphoma survivors.

Eligible Conditions
  • Lymphoma
  • Cancer Survivors

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 12 months

12 months
Change from baseline Fear of Cancer Recurrence assessed by the Cancer Worry Scale (CWS)
Change from baseline Work Ability assessed by the Work Ability Index (WAI)
Change from baseline multi-dimensional Quality of life (QoL) assessed by the Patient-Reported Outcomes Measurement Information System-29
3 months
Change of the exercise guideline as determined by comparing the active minutes captured in the Fitbit

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Lymfit exercise intervention
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Lymfit exercise intervention · No Placebo Group · N/A

Lymfit exercise intervention
Experimental Group · 1 Intervention: Lymfit exercise intervention · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER
409 Previous Clinical Trials
133,362 Total Patients Enrolled
2 Trials studying Lymphoma
68 Patients Enrolled for Lymphoma
Jewish General HospitalOTHER
136 Previous Clinical Trials
319,443 Total Patients Enrolled
1 Trials studying Lymphoma
28 Patients Enrolled for Lymphoma
McGill UniversityLead Sponsor
368 Previous Clinical Trials
978,626 Total Patients Enrolled
3 Trials studying Lymphoma
83 Patients Enrolled for Lymphoma

Eligibility Criteria

Age 18 - 39 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with lymphoma for the first time between the ages of 18 and 39.

Frequently Asked Questions

Does this medical research include elderly participants?

"This specific trial is open to patients aged between 18 and 39. In contrast, there are 308 clinical trials targeting underage participants and 1593 for persons over the age of 65." - Anonymous Online Contributor

Unverified Answer

How extensive is the sampling size of this investigation?

"That is correct. The particulars on demonstrate that the study, initiated January 15th 2022, has a current call for volunteers with 50 spots open at one site." - Anonymous Online Contributor

Unverified Answer

Are there still vacancies available to participate in this research?

"Affirmative. shows that enrollment is still open for this research trial, which was first posted on January 15th 2022 and last edited on February 24th of the same year. Currently, 50 patients are being sought out at a single medical site." - Anonymous Online Contributor

Unverified Answer

Is there a possibility I could partake in this trial?

"This research effort is seeking 50 participants aged 18-39 who have lymphoma. The list of prerequisites for enrolment include: a recent diagnosis confirmed by their hematologist, zero health issues impeding vigorous physical activity, chemotherapy administered within the last 6 months with curative intent in mind, possession of a mobile device compatible with Fitbit and capable of completing questionnaires online (in either French or English), access to an Internet connection that supports virtual coaching sessions through Zoom videoconferencing." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.